Financial Performance - For the fiscal year ending December 31, 2024, the company reported a revenue of RMB 385,482,000, a decrease of 3.8% from RMB 397,998,000 in 2023[3] - The gross profit for 2024 was RMB 20,223,000, representing a gross margin of 5.25%, slightly down from 5.37% in 2023[3] - The net loss attributable to shareholders for 2024 was RMB 27,802,000, compared to a loss of RMB 20,160,000 in 2023, indicating a worsening financial performance[3] - The company reported a basic and diluted loss per share of RMB 1.46 for 2024, compared to RMB 1.06 in 2023, indicating a decline in shareholder value[6] - The company reported a total comprehensive loss of RMB 27,802,241 for the year ended December 31, 2024[12] - The company reported a loss attributable to owners of RMB (27,802,241) in 2024, compared to a loss of RMB (20,159,658) in 2023, indicating a significant increase in losses[40] - The group reported a loss attributable to owners of RMB 27,802,241 for the year ended December 31, 2024, compared to RMB 20,159,658 in 2023, with a loss per share of RMB 1.46, up from RMB 1.06[76] Assets and Liabilities - Total assets as of December 31, 2024, amounted to RMB 332,527,000, an increase from RMB 303,278,000 in 2023[3] - Total liabilities increased to RMB 304,087,000 in 2024 from RMB 238,699,000 in 2023, reflecting a significant rise in financial obligations[3] - The company’s non-current assets decreased to RMB 98,533,261 in 2024 from RMB 112,936,039 in 2023, reflecting a reduction in long-term investments[7] - Total equity attributable to shareholders dropped to RMB 22,149,067 in 2024 from RMB 49,951,308 in 2023, highlighting a significant decline in shareholder equity[8] - The group’s asset-liability ratio was 0.91 as of December 31, 2024, compared to 0.79 in 2023, indicating an increase in financial leverage[83] Cash Flow and Liquidity - The company’s cash and cash equivalents rose to RMB 25,399,950 in 2024, up from RMB 5,934,322 in 2023, indicating improved liquidity[7] - As of December 31, 2024, the company's current liabilities were approximately RMB 279,065,167, while cash and cash equivalents stood at only RMB 25,399,950, resulting in a net current liability position of RMB 45,071,379[53] - The company incurred total employee costs of RMB 27,726,792 in 2024, up from RMB 24,361,521 in 2023[36] Revenue Breakdown - Revenue from fertilizer products was RMB 384,846,908, down from RMB 397,424,063 in the previous year, indicating a decline of 3.1%[14] - The revenue from the sale of general fertilizers was RMB 359,752,928 in 2024, down from RMB 378,821,948 in 2023, representing a decline of about 5.0%[28] - Revenue from external customers for the year ended December 31, 2024, was RMB 385,482,322, a decrease from RMB 397,998,097 in 2023, representing a decline of approximately 3.8%[22][23] Research and Development - Research and development expenses for 2024 were RMB 1,102,139, a decrease from RMB 1,319,315 in 2023, suggesting a potential shift in focus or cost management[6] - Research and development expenses were RMB 1,102,139, a decrease of 16.46% from RMB 1,319,315 in the previous year, reflecting the R&D spending of the high-tech enterprise Guangdong Fuli Long[73] Strategic Moves - The company sold 82.76% of its stake in Shanghai Weidi Network Technology Co., Ltd., marking a strategic exit from the health products segment[18] - The company has classified Shanghai Weidi as a disposal group held for sale, terminating the operation of its "health products (alcohol) and related services" business[31] - The company plans to enhance product quality and develop new environmentally friendly fertilizers in response to increasing demands for fertilizer effectiveness and environmental regulations[59] Market and Industry Outlook - The composite fertilizer market experienced structural adjustments in 2024, with nitrogen fertilizer prices fluctuating at low levels and phosphate prices supported by resource costs[59] - The demand for composite fertilizers is expected to grow due to government policies aimed at stabilizing grain production above 1.3 trillion jin, enhancing farmers' planting enthusiasm[59] Shareholder Information - Major shareholders include state-owned assets management with 182,500,000 shares (9.63%), and Xiangyong Investment with 180,000,000 shares (9.50%) as of December 31, 2024[95] - The company has not declared or paid any dividends in both 2023 and 2024[39] Compliance and Governance - The company has complied with all provisions of the Corporate Governance Code except for A.2.1 during the review year, emphasizing effective board structure and transparency to shareholders[104] - The audit committee was established in accordance with GEM listing rules and consists of three independent non-executive directors, with a focus on financial reporting and internal controls[103]
泰达生物(08189) - 2024 - 年度业绩